ReviewFrontiers in pharmacology2023

Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets.

Maylin Wong-Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.